Altered ontogenesis of central noradrenergic neurons following neonatal treatment with 6-hydroxydopamine.
D000818:Animals; D001812:Blood-Brain Barrier; D001933:Brain Stem / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism; D004027:Diencephalon / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism; D006892:Hydroxydopamines / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D013687:Telencephalon / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism
D006892:Hydroxydopamines; D011941:Receptors, Adrenergic; D009638:Norepinephrine